Ironwood Pharmaceuticals | IRWD - Bruttoergebnis Vom Umsatz

Aktienkurs
3.63
Täglich Wechseln
0.03 0.83%
Monatlich
-1.36%
Jährlich
283.92%
Q2 Prognose
3.53




Bruttoergebnis Vom Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
Agios Pharmaceuticals USD 18.09M 6.89M 2025-12
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Almirall EUR 429.87M 180.02M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Amarin USD 23.17M 961K 2025-12
Ardelyx USD 114.37M 8.02M 2025-12
Astellas Pharma JPY 456.81B 38.02B 2025-12
AstraZeneca USD 12.39B 5M 2025-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Coherus Biosciences USD 8.7M 853K 2025-12
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Incyte USD 1.39B 118.68M 2025-12
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
MacroGenics USD 31.11M 30.14M 2025-12
Moderna USD 226M 583M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Pacira USD 142.25M 11.34M 2025-12
PTC Therapeutics USD 148.38M 39.31M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Takeda JPY 790.55B 262.97B 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12